This inventor holds 1 USPTO granted patent and 7 published patent applications. Top assignee: National Cancer Center. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Sang Hyuk Lee: Innovator in Epidermal Penetration Ink Composition
Introduction
Sang Hyuk Lee is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of ink compositions, particularly focusing on epidermal penetration technologies. His innovative work aims to enhance the effectiveness of ink applications in various medical and cosmetic fields.
Latest Patents
Sang Hyuk Lee holds a patent for an epidermal penetration type ink composition. This invention comprises a fluorescent colorant that includes at least one selected from indocyanine green (ICG), cyanine, phthalocyanine, oxazine, rhodamine, and mixtures thereof. The composition also features a binder resin containing at least one of polyvinylpyrrolidone (PVP) and polyvinylbutyral (PVB), along with a solvent that includes at least one of ethanol and isopropanol. This innovative formulation is designed to improve the delivery of therapeutic agents through the skin.
Career Highlights
Sang Hyuk Lee is currently affiliated with the National Cancer Center, where he applies his expertise in developing advanced ink compositions. His work is pivotal in exploring new avenues for medical applications, particularly in cancer treatment and diagnostics.
Collaborations
He collaborates with esteemed colleagues, including Seok-ki Kim and Jin Hee Noh, to further enhance the research and development of innovative ink technologies. Their combined efforts contribute to the advancement of medical applications in their respective fields.
Conclusion
Sang Hyuk Lee's contributions to the field of epidermal penetration ink compositions highlight his innovative spirit and dedication to improving medical technologies. His work continues to pave the way for advancements in therapeutic applications, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
